Korean Drug Co Ltd

014570

Company Profile

  • Business description

    Korean Drug Co Ltd is engaged in the business of manufacture and sale of pharmaceuticals. Its products include comprehensive cold remedies, hematopoietic nutrients, central nervous system agents, digestive system agents, dermatological agents, vitamins/nutritional supplements, antibiotics, antibacterials, antipyretics, analgesics, and anti-inflammatory agents. The group manufacture and sell over-the-counter medications, including Haben, Korea's cold remedy, as well as prescription drugs for various conditions, including central nervous system (CNS) diseases such as dementia, epilepsy, stroke, and Parkinson's disease.

  • Contact

    69-10 Wonjeok-ro
    Sindun-myeon
    Gyeonggi-do
    Icheon-si
    KOR

    T: +82 316347100

    https://www.nicepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    240

Stocks News & Analysis

stocks

Sales shine but broader macro outlook darkens for this ASX share

US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks

Chart of the Week: US equity market trading at an attractive discount

The latest from our Chief US Market Strategist.
stocks

Undervalued ASX share retains wide moat rating despite regulatory pressures

Proposed price regulation impacts our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,139.1024.60-0.27%
CAC 408,263.87355.134.49%
DAX 4024,080.631,159.045.06%
Dow JONES (US)47,909.921,325.462.85%
FTSE 10010,608.88260.092.51%
HKSE25,893.02776.493.09%
NASDAQ22,634.99617.142.80%
Nikkei 22556,010.01298.41-0.53%
NZX 50 Index13,327.7173.770.56%
S&P 5006,782.81165.962.51%
S&P/ASX 2008,934.7038.10-0.42%
SSE Composite Index3,995.00104.832.69%

Market Movers